These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32887404)

  • 21. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
    Addi T; Dou L; Burtey S
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
    Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
    Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuR.
    Lai Y; Tang H; Zhang X; Zhou Z; Zhou M; Hu Z; Zhu F; Zhang L; Nie J
    Kidney Blood Press Res; 2022; 47(1):61-71. PubMed ID: 34788763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences.
    Spence JD; Urquhart BL
    Curr Neurol Neurosci Rep; 2022 Nov; 22(11):757-766. PubMed ID: 36181576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease.
    Song JY; Shen TC; Hou YC; Chang JF; Lu CL; Liu WC; Chen PJ; Chen BH; Zheng CM; Lu KC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uremic Toxin-Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome.
    Taguchi K; Elias BC; Brooks CR; Ueda S; Fukami K
    Circ J; 2019 Dec; 84(1):2-8. PubMed ID: 31827008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD.
    Briskey D; Tucker PS; Johnson DW; Coombes JS
    Nitric Oxide; 2016 Jul; 57():64-70. PubMed ID: 27164294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trimethylamine-N-oxide and cardiovascular events in chronic kidney disease].
    Dai Q; Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Nov; 44(11):1294-1299. PubMed ID: 31919326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease.
    Prokopienko AJ; West RE; Schrum DP; Stubbs JR; Leblond FA; Pichette V; Nolin TD
    Sci Rep; 2019 Nov; 9(1):15901. PubMed ID: 31685846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
    Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
    Vallianou NG; Mitesh S; Gkogkou A; Geladari E
    Curr Cardiol Rev; 2019; 15(1):55-63. PubMed ID: 29992892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-Arrhythmic Potential of Accumulated Uremic Toxins Is Mediated via Vulnerability of Action Potential Repolarization.
    van Ham WB; Cornelissen CM; Polyakova E; van der Voorn SM; Ligtermoet ML; Monshouwer-Kloots J; Vos MA; Bossu A; van Rooij E; van der Heyden MAG; van Veen TAB
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
    Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of lipids and uremic toxins in cardiovascular disease in CKD.
    Massy ZA
    Clin Exp Nephrol; 2014 Apr; 18(2):255-6. PubMed ID: 24072415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Female AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney Disease.
    Makhloufi C; Nicolas F; McKay N; Fernandez S; Hache G; Garrigue P; Brunet P; Guillet B; Burtey S; Poitevin S
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.